Synthesis and structure-activity relationships of novel neocryptolepine derivatives

Abstract

Herein we reported the synthesis of a novel series of neocryptolepine(5-methyl-5H-indolo[2,3-b]quinoline) derivatives containing different substituents at C11 using methyl 1H-indole-3-carboxylate and N-methylaniline as starting material. The target 21 compounds were evaluated for their antibacterial activity in vitro against gram-positive bacteria(B. subtilis and S. aureus) and gram-negative bacteria(E.coli and S. typhi). Almost all the tested compounds showed moderate to high activities against the four bacterial strains at the minimum inhibitory concentrations(MICs) of 1—10 μg/mL. The obtained results suggest that part of the novel synthetic neocryptolepine derivatives exhibit significant antibacterial effect against all the tested organisms.

Keywords

Neocryptolepine / Indoloquinoline / Antibacterial

References

[1] Butler M. S. J. Nat. Prod., 2004, 67: 2141.

[2] Cimanga K., Bruyne T. D., Pieters L., Claeys M., Vlietinck A. Te-trahedron Lett., 1996, 37: 1703.

[3] El Sayed I., Ramzy F., William S., El Bahanasawy M., Abdel-Staar M. M. Med. Chem. Res., 2012, 21: 4219.

[4] El Sayed I. E., Veken P. V., Dhooghe L., Hostyn S., van Baelen G., Lemière G., Maes B. U. W., Cos P., Maes L., Joossens J., Haemers A., Pieters L., Augustyns K. J. Med. Chem., 2009, 52: 2979.

[5] Jonckers T. H. M., van Miert S., Kanyanga C., Bailly C., Colson P., de Pauw-Gillet M. C., van den Heuvel H., Claeys M., Lemiere F., Esmans E. L., Rozenski J., Quirijnen L., Maes L., Dommisse R., Lemière G. L. F., Vlietinck A., Pieters L. J. Med. Chem., 2002, 45: 3497.

[6] Lavrado J., Moreira R., Paulo A. Curr. Med. Chem., 2010, 17: 2348.

[7] Lu W. J., Świtalska M., Wang L., Yonezawa M., El Sayed I. E., Wietrzyk J., Inokuchi T. Med. Chem. Res., 2013, 22: 4492.

[8] Lu W. J., Wicht K. J., Wang L., Imai K., Mei Z. W., Kaiser M., El Sayed I. E., Egan T. J., Inokuchi T. Eur. J. Med. Chem., 2013, 64: 498.

[9] Prakash T. P., Perunninakulath S. P., Santosh G. T. Curr. Org. Chem., 2011, 15: 1036.

[10] Mei Z. W., Wang L., Lu W. J., Pang C. Q., Maeda T., Peng W., Kaiser M., El Sayed I. E., Inokuchi T. J. Med. Chem., 2013, 56: 1431.

[11] Wang N., Imai K., Pang C. Q., Wang M. Q., Yonezawa M., Zhang Y., Nokami J., Inokuchi T. Bull. Chem. Soc. Jpn., 2013, 86: 864.

[12] Wang L., Świtalska M., Mei Z. W., Lu W. J., Takahara Y., Feng X. W., Sayed I. E., Wietrzyk J., Inokuchi T. Bioorg. Med. Chem., 2012, 20: 4820.

[13] Xu Y. J., Pieters L. Mini. Rev. Med. Chem., 2013, 13: 1056.

[14] Paulo A., Pimentel M., Viegas S., Pires I., Duarte A., Cabrita J., Gomes E. T. J. Ethnopharmacol., 1994, 44: 73.

[15] Paulo A., Duarte A., Gomes E. T. J. Ethnopharmacol., 1994, 44: 127.

[16] Sawer I. M., Brown M. W., Ford J. L. J. Appl. Bacteriol., 1995, 79: 314.

[17] Cimanga K., de Bruyne T., Pieters L., Totte J., Tona L., Kambu K., van den Berghe D., Vlietinck A. J. Phytomedicine, 1998, 5: 209.

[18] Mills-Robertson F. C., Aboagye F. A., Duker-Eshun G., Kaminta S., Agbeve S. Afr.^J. Pharm. Pharmacol., 2009, 3: 476.

[19] Mills-Robertson F. C., Tay S. C., Duker-Eshun G., Walana W., Badu K. Ann. Clin. Microbiol. Antimicrob., 2012, 11: 16.

[20] Molina A., Vaquero J. J., Garcia-Navio J. L., Alvarez-Builla J., Pascula-Terasa B., Gago F., Rodrigo M. M., Ballestros M. J. Org. Chem., 1996, 61: 5587.

[21] Guittat L., Alberti P., Rosu F., van Miert S., Thetiot E., Pieters L., Gabelica V. E., Pauw D., Ottaviani A., Riou J. F., Mergny J. L. Biochimie, 2003, 85: 535.

[22] Poole K. J. Pharm. Pharmacol., 2001, 53: 283.

[23] Costerton J. W., Cheng K. J. J. Antimicrob. Chemother., 1975, 1: 363.

[24] Cushnie T. P., Lamb A. J. Int.^J. Antimicrob. Agents, 2005, 26: 343.

[25] El-Essawy F. A., Boshta N. M., Alotaibi M. A., Elsayed M. S., Tara-bees R. E., Saleh A. Res. Chem. Intermed., 2016, 42: 8157.

[26] El-Essawy F. A., Boshta N. M., El-Sawaf A. K., Nassar A. A., Kha-lafallah M. S. Chem. Res. Chinese Universities, 2016, 32(6): 967.

[27] El Sayed I., El Kosy S. M., Hawata M. A., El Gokha A., Tolan A., Abd El-Sattar M. J. Am. Sci., 2011, 7: 357.

[28] Bailly C., Laine W., Baldeyrou B., de Pauw-Gillet M. C., Colson P., Houssier C., Cimanga K., van Miert S., Vlietinck A., Pieters L. Anti-Cancer Drug Des., 2000, 15: 191.

[29] Wang L., Lu W. J., Odawara T., Misumi R., Mei Z. W., Peng W., El-Sayed I. E. T., Inokuchi T. J. Heterocyclic. Chem., 2014, 51: 1106.

[30] Peczyńska-Czoch W., Pognan F., Kaczmarek, Boratyński J. J. Med. Chem., 1994, 37: 3503.

[31] Osiadacz J., PeczynÄska-Czoch W., Kaczmarek O. A. 6th Interna-tional Symposium on Molecular Aspects of Chemotherapy. 9—12 July, 1997.

[32] Kaczmarek L., Peczynska-Czoch W., Osiadacz J., Mordarski M., Sokalski W. A., Boratynski J., Marcinkowska E., Glazman-Kusnierczyk H., Radzikowski C. Bioorg. Med. Chem., 1999, 7: 2457.

[33] Hsueh P. R., Chang J. C., Teng L. J., Yang P. C., Ho S. W., Hsieh W. C., Luh K. T. J. Clin. Microbiol., 1997, 35: 1021.